[PDF][PDF] Update on the management of chronic idiopathic constipation

BE Lacy - Am J Manag Care, 2019 - bannermedicalwriting.com
Chronic idiopathic constipation (CIC), previously labeled as functional constipation, is a
highly prevalent disorder reported to healthcare providers. 1 Symptoms of constipation can …

[HTML][HTML] Efficacy and safety of Bifidobacterium quadruple viable tablets combined with mosapride citrate in the treatment of constipation in China: a systematic review …

M Luo, L Xiong, L Zhang, Q Xu - BMC gastroenterology, 2023 - Springer
Aim To analyze the efficacy and safety of Bifidobacterium quadruple viable tablets combined
with mosapride citrate for the treatment of constipation. Methods A systematic review was …

[HTML][HTML] Diagnosis and management of chronic idiopathic constipation: a narrative review from a Brazilian expert task force

MCF Passos, RC Alvariz, EA André… - Arquivos de …, 2022 - SciELO Brasil
Background Chronic idiopathic constipation (CIC) is a condition that widely affects the global
population, represents relevant healthcare resource utilization and costs, and impacts the …

[HTML][HTML] Difference in defecation desire between patients with and without chronic constipation: a large-scale Internet survey

H Ohkubo, T Takatsu, T Yoshihara… - Clinical and …, 2020 - journals.lww.com
METHODS: We conducted an online questionnaire survey targeting the Japanese general
population in 2019. DD was reported as never, rarely, usually, or always. Individuals who …

The silent threat: Nanopolystyrene and chrysene pollutants disrupt the intestinal mucosal barrier, new insights from juvenile Siniperca chuatsi

T Chen, RSS Aly, Y Shen, S Tang, Y Zhao… - Science of The Total …, 2024 - Elsevier
The intestinal mucosal barrier—comprising microbial, mechanical, chemical, and
immunological barriers—is critical to protection against pathogens and maintenance of host …

An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation

M Daniali, S Nikfar, M Abdollahi - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Chronic idiopathic constipation (CIC) is a kind of constipation in which the
patient experiences constipation more than 3 months without any identifiable cause …

Structure characterization of polysaccharides from Cistanche deserticola and their neuroprotective effects against oxidative stress in slow transit constipation mice

H Jiang, R Ma, F Ji, Y Liu, B Wang, S Fu, L Ma… - International Journal of …, 2024 - Elsevier
Oxidative stress-induced enteric neuropathy is an important factor in slow transit
constipation (STC). Cistanche deserticola crude polysaccharides (CDCP) are natural …

[HTML][HTML] Analysis of key genes for slow transit constipation based on RNA sequencing

L Yu, X Yang, W Guan, D Zhang, S Ren… - … Journal of General …, 2022 - ncbi.nlm.nih.gov
Analysis of Key Genes for Slow Transit Constipation Based on RNA Sequencing - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

[HTML][HTML] Association of per-and polyfluoroalkyl substances with constipation: The National Health and Nutrition Examination Survey (2005–2010)

Y Zhao, K Pu, Y Zheng, Y Wang, J Wang, Y Zhou - Plos one, 2024 - journals.plos.org
Background The impact of per-and polyfluoroalkyl substances (PFAS) on constipation, as
mediated through gastrointestinal absorption and perturbations to the intestinal …

[HTML][HTML] The prevalence of constipation in end-stage kidney disease patients: A cross-sectional observation study

L Zhang, F Tang, F Wang, Q Xie, M Xia, L Jiang… - Medicine, 2022 - journals.lww.com
The aim of our study was to determine the prevalence, distribution, and risk factors for
constipation in peritoneal dialysis (PD) and hemodialysis (HD) patients in our center. In this …